Steatosis and insulin resistance in response to treatment of chronic hepatitis C

Sudden Progression from Impaired Glucose Tolerance to Type 2 Diabetes after Discontinuation of Administration of Anti-Tumor Necrosis Factor-Alpha Antibody Infliximab

(2017) F. Ursini et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Insulin Resistance Predicts Rapid Virologic Response to Peginterferon/Ribavirin Combination Therapy in Hepatitis C Genotype 4 Patients

(2010) Mahmoud Khattab et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Diabetes Enhances Hepatocarcinogenesis in Noncirrhotic, Interferon-treated Hepatitis C Patients

(2010) Yusuke Kawamura et al.   AMERICAN JOURNAL OF MEDICINE

Insulin resistance in rheumatoid arthritis: the impact of the anti-TNF-α therapy

(2010) Miguel A. Gonzalez-Gay et al.   Annals of the New York Academy of Sciences

Abnormalities of lipid metabolism in hepatitis C virus infection

(2010) F. Negro   GUT

Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C

(2010) Rami Moucari et al.   GUT

Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapy

(2010) Chao-Hung Hung et al.   INTERNATIONAL JOURNAL OF CANCER

Hepatitis C virus core protein genotype 3a increases SOCS-7 expression through PPAR-  in Huh-7 cells

(2010) V. Pazienza et al.   JOURNAL OF GENERAL VIROLOGY

308 VIROLOGIC AND METABOLIC RESPONSES IN CHRONIC HEPATITIS C (CHC) PATIENTS WITH INSULIN RESISTANCE (IR) TREATED WITH PIOGLITAZONE AND PEGINTERFERON ALFA-2A PLUS RIBAVIRIN

(2010) S. Harrison et al.   JOURNAL OF HEPATOLOGY

The homeostasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients

(2010) Giovanna Fattovich et al.   LIVER INTERNATIONAL

Correlates and Prognostic Value of the First‐Phase Hepatitis C Virus RNA Kinetics during Treatment

(2009) Emanuele Durante‐Mangoni et al.   CLINICAL INFECTIOUS DISEASES

Does TNF-alpha blockade play any role in cardiovascular risk among rheumatoid arthritis (RA) patients?

(2009) Raquel Cuchacovich et al.   CLINICAL RHEUMATOLOGY

Chronic Hepatitis C Is Associated With Peripheral Rather Than Hepatic Insulin Resistance

(2009) Kerry–Lee Milner et al.   GASTROENTEROLOGY

Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin

(2009) Manuel Romero-Gómez et al.   HEPATOLOGY

Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C

(2009) Ester Vanni et al.   HEPATOLOGY

Predictive value of suppressor of cytokine signal 3 (SOCS3) in the outcome of interferon therapy in chronic hepatitis C

(2009) Hisamitsu Miyaaki et al.   HEPATOLOGY RESEARCH

Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin

(2009) Alessandro Grasso et al.   JOURNAL OF HEPATOLOGY

Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients

(2009) Chia-Yen Dai et al.   JOURNAL OF HEPATOLOGY

Hepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV/HIV infection

(2009) Kyung-Ah Kim et al.   JOURNAL OF HEPATOLOGY

Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C

(2009) Pierre-Yves Bochud et al.   JOURNAL OF HEPATOLOGY

What are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C?

(2009) Alfredo Alberti   LIVER INTERNATIONAL

Pioglitazone improves virological response to peginterferon α-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance

(2009) Mahmoud Khattab et al.   LIVER INTERNATIONAL

Hepatitis C virus and type 2 diabetes

(2009) Francesco Negro et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Insulin resistance impairs rapid virologic response in HIV/hepatitis C virus coinfected patients on peginterferon-alfa-2a

(2008) Paola Nasta et al.   AIDS

Insulin resistance is a major determinant of sustained virological response in genotype 1 chronic hepatitis C patients receiving peginterferon α-2b plus ribavirin

(2008) C.-J. CHU et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus

(2008) Bart J. Veldt et al.   HEPATOLOGY

Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C

(2008) Yasuji Arase et al.   HEPATOLOGY

Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C

(2008) Manuel Romero-Gómez et al.   JOURNAL OF HEPATOLOGY

Pioglitazone in chronic hepatitis C not responding to pegylated interferon-α and ribavirin

(2008) Kathrin Overbeck et al.   JOURNAL OF HEPATOLOGY

Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis

(2008) Donna L. White et al.   JOURNAL OF HEPATOLOGY

Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C

(2008) Christine Bernsmeier et al.   JOURNAL OF HEPATOLOGY

Interferon signaling and treatment outcome in chronic hepatitis C

(2008) M. Sarasin-Filipowicz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis

(2007) Rami Moucari et al.   GASTROENTEROLOGY

Evidence of oxidative stress as a cofactor in the development of insulin resistance in patients with chronic hepatitis C

(2007) Hironori Mitsuyoshi et al.   HEPATOLOGY RESEARCH

Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3

(2007) Hossein Poustchi et al.   JOURNAL OF HEPATOLOGY